Colo. Rev. Stat. § 25.5-5-516

Current through 11/5/2024 election

Section 25.5-5-516 - Serious mental illness - prescribed drugs

Notwithstanding any provisions of this part 5 to the contrary, and subject to any necessary federal authorization, the state board shall require a review for coverage of a new drug approved by the federal food and drug administration for a serious mental illness within ninety days after the approval of the drug.

C.R.S. § 25.5-5-516

Added by 2023 Ch. 394,§ 3, eff. 8/7/2023.

2023 Ch. 394, was passed without a safety clause. See Colo. Const. art. V, § 1(3).